Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient took two consecutive doses of Vivotif; Case reference number US-BN-2025-000287 is a spontaneous case initially received from nurse via Communications (reference number: USBAV25-0440) on 26-Feb-2025 and concerns patient of unknown age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, as reported, the patient took two consecutive doses of Vivotif (batch number: unknown) at unknown doses, or route of administration for unknown indication (explicitly coded as 'Inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if the patient experienced any adverse event. No further information was provided.; Reporter's Comments: A patient of unknown age and gender took two consecutive doses of Vivotif for unknown indication, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due Vivotif. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown age and gender took two consecutive doses of Vivotif for unknown indication, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due Vivotif. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.